31 – 40 of 105
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Granzyme B degraded type IV collagen products in serum identify melanoma patients responding to immune checkpoint blockade
- Contribution to journal › Article
-
Mark
MicroRNA-21-enriched exosomes as epigenetic regulators in melanomagenesis and melanoma progression : The impact of western lifestyle factors
- Contribution to journal › Scientific review
-
Mark
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
- Contribution to journal › Article
- 2019
-
Mark
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR)
- Contribution to journal › Article
-
Mark
Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition
- Contribution to journal › Article
-
Mark
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
- Contribution to journal › Article
-
Mark
Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells
- Contribution to journal › Article
-
Mark
Establishment of Melanoma Tumor Xenograft Using Single Cell Line Suspension and Co-injection of Patient-Derived T Cells in Immune-Deficient NSG Mice
- Contribution to journal › Article
- 2018
-
Mark
The genetic evolution of melanoma
(2018) p.105-114
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis
- Contribution to journal › Article
